Metropolitan Life Insurance Company (MetLife)’s OptimizeRx OPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-925
| Closed | -$11.2K | – | 1476 |
|
|
2024
Q1 | $11.2K | Hold |
925
| – | – | ﹤0.01% | 2090 |
|
|
2023
Q4 | $13.2K | Hold |
925
| – | – | ﹤0.01% | 2080 |
|
|
2023
Q3 | $7.2K | Hold |
925
| – | – | ﹤0.01% | 2348 |
|
|
2023
Q2 | $13.2K | Buy |
925
+298
| +48% | +$4.26K | ﹤0.01% | 2145 |
|
|
2023
Q1 | $9.17K | Sell |
627
-479
| -43% | -$7.01K | ﹤0.01% | 2190 |
|
|
2022
Q4 | $18.6K | Hold |
1,106
| – | – | ﹤0.01% | 2052 |
|
|
2022
Q3 | $16.4K | Hold |
1,106
| – | – | ﹤0.01% | 2120 |
|
|
2022
Q2 | $30.3K | Hold |
1,106
| – | – | ﹤0.01% | 1813 |
|
|
2022
Q1 | $41.7K | Sell |
1,106
-3,371
| -75% | -$127K | ﹤0.01% | 1698 |
|
|
2021
Q4 | $278K | Hold |
4,477
| – | – | ﹤0.01% | 1786 |
|
|
2021
Q3 | $383K | Sell |
4,477
-673
| -13% | -$57.6K | 0.01% | 1625 |
|
|
2021
Q2 | $319K | Hold |
5,150
| – | – | ﹤0.01% | 1813 |
|
|
2021
Q1 | $251K | Hold |
5,150
| – | – | ﹤0.01% | 1860 |
|
|
2020
Q4 | $160K | Hold |
5,150
| – | – | ﹤0.01% | 2086 |
|
|
2020
Q3 | $107K | Buy |
+5,150
| New | +$107K | ﹤0.01% | 2174 |
|